semaglutide fda label Approval vs Compounded Alternatives FDA adds warning for intestinal

Each aliquot should receive clear labeling documenting the original lot number, aliquoting date, peptide concentration, and storage conditions to maintain complete traceability throughout research projects or manufacturing processes

Maintenance Strategies For those who must discontinue treatment, several strategies may help minimize regain

cash-pay distinctions to patients

Some healthcare providers may prescribe Rybelsus "off-label" for weight management, as it contains the same active ingredient (semaglutide) as Wegovy, an FDA and UK-approved weight-loss medication

doi: 10.1007/s00415-009-5228-x Ridker PM, Buring JE, Cook NR, Rifai N